Aarkstore Enterprise -- Idiopathic Pulmonary Fibrosis - Pipeline Assessment And Market Forecasts To

Aarkstore announce a new report " Idiopathic Pulmonary Fibrosis - Pipeline Assessment

and Market Forecasts to 2017" through its vast collection of market research report.

Summary

Pharmaceutical and healthcare report, Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Market Forecasts to 2017 is an essential source of information and analysis on the global idiopathic pulmonary fibrosis market. The report identifies the key trends shaping and driving the global idiopathic pulmonary fibrosis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global idiopathic pulmonary fibrosis sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis team of industry experts.

The global Idiopathic Pulmonary Fibrosis (IPF) market was valued at $88m in 2009. It is expected to increase with a compound annual growth rate (CAGR) of 23% from $88m in 2009 to $462m by 2017. Earlier, the IPF market was underserved due to a lack of approved products. In October 2008, the Japanese manufacturer Shionogi received approval for Pirespa in Japan. It is under regulatory review for approval in the US and EU. The expected increase in sales is due to the expected approval of Pirespa in the US and the EU and also the expected launch of Tracleer and Letiaris. Growth in the IPF market is being driven by the sales of Pirespa, off-label drug use and the anticipated approval of Letiaris and Tracleer. Gileads Letiaris and Actelions Tracleer are the most anticipated molecules in the IPF market.

Scope

The report provides information on the key driver and challenges of the idiopathic pulmonary fibrosis market. Its scope includes:

- Annualized global idiopathic pulmonary fibrosis market revenues data from 2001 to 2009, forecast forward for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include enzyme inhibitors, protein inhibitors, endothelin A antagonists, combination therapy, TNF alpha antagonists, platelet aggregation inhibitors, interferon alpha, interleukin inhibitors, immunosuppresants, growth hormone inhibitors, gene therapy, LPA1 receptor antagonists, tumor growth factor inhibitors and NK-1 antagonists.

- Analysis of the current and future market competition in the global idiopathic pulmonary fibrosis market. Key market players covered are Gilead Sciences, Actelion Ltd., Amgen Inc., InterMune Inc. and Amarillo Biosciences.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the future market associated with idiopathic pulmonary fibrosis therapeutics.

For more information, please visit:

http://www.aarkstore.com/reports/Idiopathic-Pulmonary-Fibrosis-Pipeline-Assessment-and-Market-Forecasts-to-2017-39100.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise -- Acne - Pipeline Assessment And Market Forecasts To 2017 Building a Profitable Blog Without Spending a Dime Global Flexible Display Market 2009-2013 Truth Behind Monavie Multi Level Marketing Tahitian Noni Review Mlm Marketing Web Design For The Uk Market Millionaire Profit Secrets Review - What's Inside? Eventos e o Marketing Jurídico 3 Ways to Increase Your Profits on an Ecommerce Website National Export Initiative Marketing Outreach Effort Finds Champion in TR Cutler, Inc Online Marketing By Using A Different Perspective - Or, The Way To Think Outside Of The Box Viral Marketing - A Free Way to Promote and Profit Volatile Market Conditions Affecting Exchange Rates - Gerardassociates